SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001011240-03-000048
Filing Date
2003-06-16
Accepted
2003-06-16 17:25:45
Documents
1
Period of Report
2003-06-12

Document Format Files

Seq Description Document Type Size
1 kvf4schell061603_ex.html 4  
1 kvf4schell061603_ex.xml 4 2472
  Complete submission text file 0001011240-03-000048.txt   4367
Mailing Address 2503 S HANLEY RD ST LOUIS MO 63144
Business Address 2503 S HANLEY RD ST LOUIS MO 63144 3146456600
KV PHARMACEUTICAL CO /DE/ (Issuer) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address INKINE PHARMACEUTICAL CO INC 1787 SENTRY PARK WEST STE 440 BLUE BALL PA 19422
Business Address C/O INKINE PHARMACEUTLCAL CO INC 1787 SENTRY PARK WEST STE 440 BLUE BALL PA 19422 2152836866
SCHELLENGER NORMAN D (Reporting) CIK: 0001206824 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-09601 | Film No.: 03746224